Last Updated: November 8, 2026

Details for Patent: 10,758,532

Name: Drug Patent Intelligence for US Patent 10758532
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which drugs does patent 10,758,532 protect, and when does it expire?

Patent 10,758,532 protects ATZUMI and is included in one NDA.

This patent has seven patent family members in five countries.

Summary for Patent: 10,758,532

Title:	Compositions, devices, and methods for treating or preventing headaches
Abstract:	Disclosed herein are pharmaceutical compositions, devices, their combinations, and their uses thereof for example in treating or preventing headaches.
Inventor(s):	John KOLLINS, Fumiyoshi IWASHIMA, Detlef Albrecht, Robert David Schultz
Assignee:	Satsuma Pharmaceuticals Inc
Application Number:	US16/710,538
Patent Claim Types: see list of patent claims	Use; Composition; Delivery; Device;

Drugs Protected by US Patent 10,758,532

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Satsuma Pharms	ATZUMI	dihydroergotamine mesylate	POWDER;NASAL	217901-001	Apr 30, 2025		RX	Yes	Yes	10,758,532	⤷ Start Trial	Y				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,758,532

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	3122396	⤷ Start Trial
China	113423400	⤷ Start Trial
China	120284965	⤷ Start Trial
European Patent Office	3893877	⤷ Start Trial
United Kingdom	201919203	⤷ Start Trial
United Kingdom	2581431	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.